Physicians' adherence to tight control treatment strategy and combination DMARD therapy are additively important for reaching remission and maintaining working ability in early rheumatoid arthritis: a subanalysis of the FIN-RACo trial

V Rantalaiho; H Kautiainen; M Korpela; K Puolakka; H Blåfield; K Ilva; P Hannonen; M Leirisalo-Repo; T Möttönen

doi:10.1136/annrheumdis-2013-204271

Physicians' adherence to tight control treatment strategy and combination DMARD therapy are additively important for reaching remission and maintaining working ability in early rheumatoid arthritis: a subanalysis of the FIN-RACo trial

V Rantalaiho, H Kautiainen, M Korpela, K Puolakka, H Blåfield, K Ilva, P Hannonen, M Leirisalo-Repo, T Möttönen

Research output: Contribution to journal › Article › Scientific › peer-review

15 Citations (Scopus)

Original language	English
Pages (from-to)	788-790
Journal	ANNALS OF THE RHEUMATIC DISEASES
Volume	73
Issue number	4
DOIs	https://doi.org/10.1136/annrheumdis-2013-204271
Publication status	Published - 2014
Publication type	A1 Journal article-refereed

Publication forum classification

No publication forum level

Access to Document

10.1136/annrheumdis-2013-204271

Cite this

Rantalaiho, V., Kautiainen, H., Korpela, M., Puolakka, K., Blåfield, H., Ilva, K., Hannonen, P., Leirisalo-Repo, M., & Möttönen, T. (2014). Physicians' adherence to tight control treatment strategy and combination DMARD therapy are additively important for reaching remission and maintaining working ability in early rheumatoid arthritis: a subanalysis of the FIN-RACo trial. ANNALS OF THE RHEUMATIC DISEASES, 73(4), 788-790. https://doi.org/10.1136/annrheumdis-2013-204271

@article{e6b367d524f84e128c928aeef9dd6475,

title = "Physicians' adherence to tight control treatment strategy and combination DMARD therapy are additively important for reaching remission and maintaining working ability in early rheumatoid arthritis: a subanalysis of the FIN-RACo trial",

author = "V Rantalaiho and H Kautiainen and M Korpela and K Puolakka and H Bl{\aa}field and K Ilva and P Hannonen and M Leirisalo-Repo and T M{\"o}tt{\"o}nen",

year = "2014",

doi = "10.1136/annrheumdis-2013-204271",

language = "English",

volume = "73",

pages = "788--790",

journal = "ANNALS OF THE RHEUMATIC DISEASES",

issn = "0003-4967",

publisher = "BMJ Publishing Group",

number = "4",

}

Rantalaiho, V, Kautiainen, H, Korpela, M, Puolakka, K, Blåfield, H, Ilva, K, Hannonen, P, Leirisalo-Repo, M & Möttönen, T 2014, 'Physicians' adherence to tight control treatment strategy and combination DMARD therapy are additively important for reaching remission and maintaining working ability in early rheumatoid arthritis: a subanalysis of the FIN-RACo trial', ANNALS OF THE RHEUMATIC DISEASES, vol. 73, no. 4, pp. 788-790. https://doi.org/10.1136/annrheumdis-2013-204271

Physicians' adherence to tight control treatment strategy and combination DMARD therapy are additively important for reaching remission and maintaining working ability in early rheumatoid arthritis: a subanalysis of the FIN-RACo trial. / Rantalaiho, V; Kautiainen, H; Korpela, M et al.
In: ANNALS OF THE RHEUMATIC DISEASES, Vol. 73, No. 4, 2014, p. 788-790.

Research output: Contribution to journal › Article › Scientific › peer-review

TY - JOUR

T1 - Physicians' adherence to tight control treatment strategy and combination DMARD therapy are additively important for reaching remission and maintaining working ability in early rheumatoid arthritis: a subanalysis of the FIN-RACo trial

AU - Rantalaiho, V

AU - Kautiainen, H

AU - Korpela, M

AU - Puolakka, K

AU - Blåfield, H

AU - Ilva, K

AU - Hannonen, P

AU - Leirisalo-Repo, M

AU - Möttönen, T

PY - 2014

Y1 - 2014

U2 - 10.1136/annrheumdis-2013-204271

DO - 10.1136/annrheumdis-2013-204271

M3 - Article

SN - 0003-4967

VL - 73

SP - 788

EP - 790

JO - ANNALS OF THE RHEUMATIC DISEASES

JF - ANNALS OF THE RHEUMATIC DISEASES

IS - 4

ER -

Rantalaiho V, Kautiainen H, Korpela M, Puolakka K, Blåfield H, Ilva K et al. Physicians' adherence to tight control treatment strategy and combination DMARD therapy are additively important for reaching remission and maintaining working ability in early rheumatoid arthritis: a subanalysis of the FIN-RACo trial. ANNALS OF THE RHEUMATIC DISEASES. 2014;73(4):788-790. doi: 10.1136/annrheumdis-2013-204271